Materialise NV (EBR:MTLS)
| Market Cap | 279.79M +17.2% |
| Revenue (ttm) | 267.63M +0.3% |
| Net Income | 7.72M -42.6% |
| EPS | 0.13 -42.9% |
| Shares Out | n/a |
| PE Ratio | 36.25 |
| Forward PE | 38.33 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 3,496 |
| Open | n/a |
| Previous Close | 4.560 |
| Day's Range | n/a |
| 52-Week Range | 4.300 - 5.600 |
| Beta | 1.20 |
| RSI | 45.44 |
| Earnings Date | Apr 23, 2026 |
About Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing tec... [Read more]
Financial Performance
In 2025, Materialise NV's revenue was 267.63 million, an increase of 0.33% compared to the previous year's 266.77 million. Earnings were 7.72 million, a decrease of -42.56%.
Financial StatementsNews
Materialise NV to Report First Quarter 2026 Earnings on Thursday, May 7, 2026
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise to Transfer RapidFit Business to Its Management Team
Leuven (BELGIUM), March 31, 2026 (GLOBE NEWSWIRE) -- Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing softw...
Materialise NV Earnings Call Transcript: Q4 2025
Revenue grew 6.8% in Q4 2025, with strong medical segment growth offsetting manufacturing declines. 2026 guidance anticipates continued double-digit medical growth, stable software, and ongoing manufacturing headwinds, with adjusted EBIT expected at EUR 10–12 million.
Materialise Reports Fourth Quarter and Full Year 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)---- $MTLS--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and se...
Materialise NV to Report Fourth Quarter 2025 Earnings on Thursday, February 19, 2026
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise Successfully Launched on Euronext Brussels – Information on the Total Number of Voting Rights and Shares
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, t...
Materialise to Hold Extraordinary Shareholders' Meeting on November 14, 2025
LEUVEN, Belgium, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it ...
Materialise to Pursue Additional Listing on Euronext Brussels and Potential ADS Buyback Program
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Nasdaq: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announ...
Materialise NV Earnings Call Transcript: Q3 2025
Q3 2025 saw strong double-digit growth in the medical segment, offsetting declines in software and manufacturing due to macroeconomic headwinds. Gross margin remained robust at 56.8%, and guidance for FY 2025 was maintained, with confidence in future growth as market conditions improve.
Materialise Reports Third Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a global leader in 3D-printed medical devices and software and a pioneer in additive manufacturing software and services, today announce...
Materialise NV to Report Third Quarter 2025 Earnings on Tuesday, October 28, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q2 2025
Q2 2025 saw strong double-digit growth in the medical segment, offset by declines in software and manufacturing due to macroeconomic and FX headwinds. Revenue guidance for the year was slightly reduced, but profitability guidance was maintained, with cost control and strategic investments supporting resilience.
Materialise Reports Second Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...
Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025
LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it w...
Materialise NV Earnings Call Transcript: Q1 2025
Revenue grew 4% year-over-year in Q1 2025, led by strong medical segment growth, while software and manufacturing faced headwinds. Net loss was EUR 0.5 million due to FX impacts, but cash flow remained strong. Full-year guidance is maintained despite expected Q2 challenges.
Materialise Reports First Quarter 2025 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...
Materialise NV to Report First Quarter 2025 Earnings on Thursday, April 24, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q4 2024
2024 saw 4% revenue growth and stable adjusted EBIT despite macroeconomic headwinds, with strong performance in medical and aerospace offset by weakness in manufacturing and automotive. 2025 guidance anticipates continued growth in medical and software, but ongoing challenges in manufacturing due to European market conditions.
Materialise Reports Fourth Quarter and Full Year 2024 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software solutions and of sophisticated 3D printing services, today announced i...
Materialise NV to Report Fourth Quarter 2024 Earnings on Thursday, February 20, 2025
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q3 2024
Q3 2024 saw revenue rise 14% to €68.7M, with strong growth in medical and all segments profitable. Guidance for full-year revenue and EBIT is maintained, while investments in ACTech and software partnerships support future growth.
Materialise Reports Third Quarter 2024 Results
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financi...
Materialise NV to Report Third Quarter 2024 Earnings on Thursday, October 24, 2024
LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (NASDAQ: MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release f...
Materialise NV Earnings Call Transcript: Q2 2024
Q2 2024 saw record revenue of €68.8M (+6.2% YoY), strong growth in all segments, and a net profit of €3.9M. Medical led with 13% revenue growth, while software recurring revenue surpassed 70%. Full-year guidance is maintained despite integration costs from the FEops acquisition.